By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback